Liver Cancer (Hepatocellular Carcinoma) clinical trials
Showing 101–150 of 188 active trials. Describe your situation to see which ones look like a fit.
- A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
- Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- A Study of DM005 in Patients With Advanced Solid Tumors
- Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies
- Anti-PD-1 mAb Plus Metabolic Modulator in Solid Tumor Malignancies
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- Study of SGN1 in Patients With Advanced Solid Tumor
- Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
- A Beta-only IL-2 ImmunoTherapY Study
- Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors
- A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
- Evaluating Novel Therapies in ctDNA Positive GI Cancers
- Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
- Y-90 Treatment Response Using Transarterial Radioembolization
- A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
- CEUS vs. AMRI for HCC Detection in Patients With Indeterminate Liver Nodules
- HepQuant: Study to Assess the Role of Blood-based Biomarkers and Quantitative MR Imaging for Patients Receiving Radiation Therapy for Liver Cancer
- A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
- National Liver Cancer Screening Trial
- Computed Tomography in Diagnosing Patients With Pancreatic or Hepatobiliary Cancer
- Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- GNOS-PV02 Personalized Neoantigen Vaccine and Plasmid Encoded IL-12 (INO-9012) Versus Active Surveillance in Subjects With High-Risk HCC
- Adaptive Dosing of Immune Checkpoint Inhibitors for Hepatocellular Carcinoma
- Project for Multi-Omics-Based Early Detection of Hepatocellular Carcinoma (PROMETHEA Study)
- Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
- Liquid Biopsy for Hepatocellular Carcinoma Molecular Characterization After Y90
- PSMA PET for the Staging and Management of Hepatocellular Carcinoma
- An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
- Observational Study Protocol: LIVER-R
- Multi-analyte Blood Test Clinical Trial
- Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
- Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
- A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
- Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
- DRAGON Registry - International Multicenter Registry and Medical Image Bank for Patients With Primarily Unresectable Liver Cancer or Liver Metastases That Underwent Combined Portal and Hepatic Vein Embolization (PVE/HVE) to Increase Future Liver Remnant Before Resection.
- A Phase I/II Study of CS2009 in Participants With Advanced Solid Tumors
- A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors
- A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors
- A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
- Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- A Multicenter Cancer Biospecimen Collection Study
- Molecular Basis of Pediatric Liver Cancer
- Comparison of ALD, NASH, and Healthy Control Patients
- A First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
- Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients
- Y90 Radioembolization Dose Delivery and Radiation Exposure Assessment
- Psychoeducational Intervention for Patients With Hepatocellular Carcinoma
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.